BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that Ralph Kern, M.D., MHSc, Chief Operating Officer and Chief Medical Officer, will be a panelist at the 13th Annual Neurotech Investing & Partnering Conference, taking place May 1-2 in Boston, Massachusetts.